| Product Name |
CAS Registry Number |
Molecular Formula |
| (11bR)-4-Hydroxy-2,6-bis(2,4,6-tricyclohexylphenyl)-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 4-oxide | 1359764-39-8 | C68H81O4P |
| N-Hydroxy-3,5-bis(trifluoromethyl)benzenecarboximidamide | 72111-09-2 | C9H6F6N2O |
| 4-Hydroxy-3',5'-Bis(Trifluoromethyl)-[1,1'-Biphenyl]-3-carboxylic Acid | 893638-28-3 | C15H8F6O3 |
| 2-Hydroxy-alpha,alpha-bis(trifluoromethyl)cyclopentanemethanol | 34844-38-7 | C8H10F6O2 |
| (11bS)-4-Hydroxy-2,6-bis[4-(trifluoromethyl)phenyl]-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 4-oxide | 1264573-23-0 | C34H19F6O4P |
| (11bR)-4-Hydroxy-2,6-bis[4-(trifluoromethyl)phenyl]-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 4-oxide | 791616-59-6 | C34H19F6O4P |
| [(2S,3R,4S,5R,6R)-5-Hydroxy-2,3-Bis[(3,4,5-Trihydroxybenzoyl)Oxy]-6-[(3,4,5-Trihydroxybenzoyl)Oxymethyl]Oxan-4-Yl] 3,4,5-Trihydroxybenzoate | 79886-50-3 | C34H28O22 |
| (11bR)-4-Hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 4-oxide | 791616-63-2 | C50H57O4P |
| (11bS)-4-Hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 4-oxide | 874948-63-7 | C50H57O4P |
| 6beta-Hydroxy-17alpha-boldenone | 934536-49-9 | C19H26O3 |
| Hydroxy Brimonidine | 1216379-05-3 | C11H12BrN5O |
| 6-Hydroxybromantane | 1007310-57-7 | C16H20BrNO |
| 5-Hydroxy Bromantane | 560070-28-2 | C16H20BrNO |
| 3-Hydroxybromazepam | 13132-73-5 | C14H10BrN3O2 |
| N-Hydroxy-P-Bromobenzenesulfonamide | 1984-32-3 | C6H6BrNO3S |
| 2-Hydroxy-3-bromo-4-methylpyridine | 18368-59-7 | C6H6BrNO |
| 2-Hydroxy-5-bromopyridine | 13466-38-1 | C5H4BrNO |
| 4-Hydroxy-5-Bromoquinoline | 723283-89-4 | C9H6BrNO |
| 5-Hydroxybucindolol | 99541-39-6 | C22H25N3O3 |
| 23-Hydroxybudesonide | 109423-03-2 | C25H34O7 |
| 6alpha-Hydroxy Budesonide | 577777-51-6 | C25H34O7 |
| 6-beta-Hydroxy Budesonide | 88411-77-2 | C25H34O7 |
| 14beta-Hydroxybufa-3,5,20,22-Tetraenolide | 545-51-7 | C24H30O3 |
| 3beta-Hydroxy-5beta-Bufa-14,20,22-Trienolide | 7439-77-2 | C24H32O3 |
| 1'-Hydroxybufuralol | 57704-16-2 | C16H23NO3 |
| 4-Hydroxybunitrolol | 68808-74-2 | C14H20N2O3 |
| (R,R)-Hydroxy Bupropion | 192374-15-5 | C13H18ClNO2 |
| Hydroxybupropione | 92264-81-8 | C13H18ClNO2 |
| 5-Hydroxybuspirone | 105496-33-1 | C21H31N5O3 |
| 6-Hydroxy Buspirone-d8 | 1189644-16-3 | C21H23D8N5O3 |
| 3-Hydroxybutanal | 107-89-1 | C4H8O2 |
| 2-Hydroxybutanamide | 206358-12-5 | C4H9NO2 |
| 2-(2H)Hydroxybutane | 4712-39-4 | C4H9DO |
| 2-hydroxy-Butanedioate lithium salt (1:1) | 94333-48-9 | C4H4LiO5 |
| 2-Hydroxybutanedioic Acid | 78644-42-5 | C4H6O5 |
| 2-Hydroxy-Butanedioic Acid Ammonium Salt (1:2) | 6283-27-8 | C4H9NO5 |
| 2-Hydroxy-Butanedioic Acid 1,4-Bis(16-Methylheptadecyl) Ester | 67763-18-2 | C40H78O5 |
| 2-Hydroxy-Butanedioic Acid Calcium Salt (1:1) | 16426-50-9 | C4H4CaO5 |
| (2S)-2-Hydroxybutanedioic acid compd. with 2-amino-2-methyl-N-[(1R)-2-[(4S,5R)-2-methyl-1-oxo-4-phenyl-2,7-diazaspiro[4.5]dec-7-yl]-2-oxo-1-[(phenylmethoxy)methyl]ethyl]propanamide (1:?) | 1415235-63-0 | C29H38N4O4.x(C4H6O5) |
| (2R)-2-hydroxy-Butanedioic acid compd. with (2R)-(2R)-2-(2,5-difluorophenyl)pyrrolidine (1:1) | 1919868-77-1 | C10H11F2N.C4H6O5 |
| (2S)-2-Hydroxybutanedioic acid compd. with (alphaR)-N,alpha-dimethyl-3,5-bis(trifluoromethyl)benzenemethanamine | 935534-56-8 | C11H11F6N.C4H6O5 |
| 2-Hydroxy-Butanedioic Acid 4-(2-Ethylhexyl)1-(9-Octadecen-1-Yl) Ester | 93981-22-7 | C30H56O5 |
| Hydroxy-Butanedioic acid ion(2)- | 149-61-1 | C4H4O5 |
| hydroxy-Butanedioic acid mixt. with benzoic acid and 2-hydroxybenzoic acid | 138230-26-9 | C18H18O10 |
| 2-Hydroxy-Butanedioic Acid Potassium Salt (1:2) | 585-09-1 | C4H4K2O5 |
| (2S)-2-Hydroxy-Butanedioic Acid Sodium Salt (1:2) | 138-09-0 | C4H4Na2O5 |
| 2-Hydroxy-Butanedioic Acid Sodium Salt Hydrate (1:2:1) | 64887-73-6 | C4H6Na2O6 |
| 2-Hydroxy-Butanedioic Acid Sodium Salt Hydrate (1:2:3) | 64887-74-7 | C4H10Na2O8 |
| (S)-Hydroxy-Butanedioic-D3 Acid | 59652-74-3 | |
| (S)-3-Hydroxybutanenitrile | 123689-95-2 | C4H7NO |